ACRX
AcelRx (ACRX) Tumbles After Stock Offering Prices at Deep Discount
Shares of biotechnology company AcelRx (ACRX) are tumbling – down nearly 17% as of this writing. The reason?
Here’s Why AcelRx Pharmaceuticals (ACRX) Stock Skyrocketed Today
On a day like today, when the entire stock market is under pressure, you must have done something right to see your stock …
This Analyst Cheers for AcelRx (ACRX), the Little Opioid Company that Could
Drug company AcelRx (ACRX) is likely celebrating its first win after getting news from the Food and Drug Administration (FDA) late Friday afternoon …
AcelRx (ACRX) Stock Wins Another Price Target Hike Following Promising News on the Regulatory Front
Investors are jumping in and out ahead of a Food and Drug Administration (FDA) decision on AcelRx’s (ACRX) opioid pain drug Dsuvia, with …
Acelrx (ACRX) Stock Is Firing on All Cylinders; Cantor Boosts Price Target
Acelrx’s (ACRX) shares popped over 20% in pre-market trading Monday, following indications that the U.S.
Why Analysts See Solid Upside Potential for Ocular Therapeutix (OCUL), Catalyst Pharmaceuticals (CPRX), and AcelRx (ACRX)
Ocular Therapeutix (OCUL), Catalyst Pharmaceuticals (CPRX) and AcelRx Pharmaceuticals (ACRX) look forward to important regulatory approval decisions this year. Could these catalysts give these small …
Trevena’s (TRVN) Briefing Documents Have Little Read-Across to AcelRx’s (ACRX) Dsuvia, Says Oppenheimer
The Food and Drug Administration (FDA) is scheduled to hold an advisory committee meeting on Friday to review AcelRx’s (ACRX) pain medication Dsuvia. …
Here’s Why You Shouldn’t Get Too Excited About AcelRx Pharmaceuticals (ACRX) Stock
Not everyone is excited about AcelRx Pharmaceuticals (NASDAQ:ACRX), which focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute …
AcelRx (ACRX): Shoring up the Balance Sheet by Selling Stock Comes with a Price
Shares of drug maker AcelRx Pharmaceuticals (NASDAQ:ACRX) slumped on Thursday, falling 13% as of 10:34 a.m.
Analysts Dig Into Three Volatile Biotech Stocks: AcelRx Pharmaceuticals Inc (ACRX), Ardelyx Inc (ARDX), and Trevena Inc (TRVN)
Analysts are cautious to sure-fire confident on mover and shakers sending the Street into a frenzy today.
